We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$57.8B
AUM Growth
-$2.88B
Cap. Flow
+$1.24B
Cap. Flow %
2.14%
Top 10 Hldgs %
45.42%
Holding
2,491
New
223
Increased
1,138
Reduced
765
Closed
178

Sector Composition

Rank Sector Weight
1 Technology 4.36%
2 Financials 2.9%
3 Consumer Discretionary 1.73%
4 Healthcare 1.64%
5 Consumer Staples 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SER icon
2126
Serina Therapeutics
SER
$31M
$41K ﹤0.01%
2,057
CLSK icon
2127
CleanSpark
CLSK
$3.73B
$40K ﹤0.01%
12,693
-2,830
-18% -$12.2K
FOSL icon
2128
Fossil Group
FOSL
$239M
$40K ﹤0.01%
11,609
+106
+0.9% +$544
CRDF icon
2129
Cardiff Oncology
CRDF
$64.3M
$39K ﹤0.01%
+25,575
New +$61.5K
QCOM icon
2130
PUT
Qualcomm
QCOM
$176B
$39K ﹤0.01%
4,400
-100
-2% -$13.7K
FXE icon
2131
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$331M
$38K ﹤0.01%
+3,200
New +$297K
GGN
2132
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$38K ﹤0.01%
11,658
-1,361
-10% -$4.65K
INSG icon
2133
Inseego
INSG
$108M
$38K ﹤0.01%
1,826
+259
+17% +$6.26K
ATAI icon
2134
AtaiBeckley Inc
ATAI
$2.66B
$37K ﹤0.01%
11,112
-100
-0.9% -$411
NEUE
2135
DELISTED
NeueHealth
NEUE
$37K ﹤0.01%
437
+259
+146% +$34.4K
OMER icon
2136
Omeros
OMER
$709M
$36K ﹤0.01%
11,270
SWIM icon
2137
Latham Group
SWIM
$646M
$36K ﹤0.01%
+10,000
New +$57.1K
AMRN
2138
Amarin Corp
AMRN
$284M
$35K ﹤0.01%
1,625
+761
+88% +$20.4K
GSAT icon
2139
Globalstar
GSAT
$10.2B
$35K ﹤0.01%
1,461
+262
+22% +$6.32K
UPS icon
2140
PUT
United Parcel Service
UPS
$97.6B
$35K ﹤0.01%
1,500
ONCT
2141
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$35K ﹤0.01%
1,972
CRBP icon
2142
Corbus Pharmaceuticals
CRBP
$170M
$34K ﹤0.01%
6,901
GALT icon
2143
Galectin Therapeutics
GALT
$229M
$34K ﹤0.01%
21,048
POWW icon
2144
Outdoor Holding Co
POWW
$239M
$34K ﹤0.01%
11,768
+100
+0.9% +$427
RDHL
2145
Redhill Biopharma
RDHL
$3.85M
$34K ﹤0.01%
68
VLTA
2146
DELISTED
Volta Inc.
VLTA
$34K ﹤0.01%
28,320
+7,850
+38% +$15.9K
KRMD icon
2147
KORU Medical Systems
KRMD
$176M
$33K ﹤0.01%
14,667
SABS icon
2148
SAB Biotherapeutics
SABS
$268M
$33K ﹤0.01%
4,752
+99
+2% +$983
SLQT icon
2149
SelectQuote
SLQT
$114M
$33K ﹤0.01%
45,063
-504
-1% -$837
SRXH
2150
SRX Global
SRXH
$35.1M
$32K ﹤0.01%
20
-115
-85% -$409K

Similar funds

Creative Planning's Q3 2022 Portfolio in Review

As of Q3 2022, Creative Planning held 2,491 positions worth $57.8B, down 4.8% from $60.7B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning's Q3 2022 filing shows 223 new, 1,138 increased, 765 reduced and 178 closed positions. Its largest new stake was Greenlane Holdings: 4 shares worth $4.19M. The largest sale was iShares Core S&P 500 ETF, an estimated $168M.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.5% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Creative Planning's largest Q3 2022 buy was Greenlane Holdings: 4 shares worth $4.19M.
  • Creative Planning added most to Schwab US Large- Cap ETF in Q3 2022, an estimated $445M increase.
  • Creative Planning's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $168M.
  • Creative Planning fully exited BNY Mellon US Small Cap Core Equity ETF in Q3 2022, selling an estimated $16.3M.
  • Creative Planning's ten largest holdings make up 45% of its $57.8B portfolio in Q3 2022.
  • Creative Planning opened 223 new positions and closed 178 in Q3 2022.
  • Creative Planning's portfolio value fell 4.8% quarter-over-quarter to $57.8B.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.